Pictet Asset Management (UK)’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$20.4M Sell
209,652
-8,373
-4% -$747K 0.02% 514
2021
Q1
$19.2M Buy
218,025
+51,548
+31% +$4.79M 0.02% 502
2020
Q4
$15.9M Buy
166,477
+32,758
+24% +$3.38M 0.02% 526
2020
Q3
$15.2M Buy
133,719
+14,967
+13% +$1.57M 0.02% 472
2020
Q2
$11.7M Sell
118,752
-27,811
-19% -$2.22M 0.02% 498
2020
Q1
$9.43M Buy
+146,563
New +$10.3M 0.02% 492

Other funds holding TNDM

Pictet Asset Management (UK)'s TNDM Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Tandem Diabetes Care (TNDM) stake by 3.8% in Q2 2021, selling an estimated $747K and leaving 209,652 shares worth $20.4M. The position accounts for 0.02% of the portfolio, ranked #514.

Pictet Asset Management (UK) first reported a position in TNDM in Q1 2020 and has held it in 6 quarters since. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2021.

  • Pictet Asset Management (UK) held 209,652 shares of Tandem Diabetes Care worth $20.4M as of Q2 2021.
  • Pictet Asset Management (UK) sold 8,373 Tandem Diabetes Care shares in Q2 2021, an estimated $747K.
  • Tandem Diabetes Care made up 0.02% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #514 holding.
  • Pictet Asset Management (UK) first reported a position in Tandem Diabetes Care in Q1 2020 and has held it in 6 quarters since.
  • 303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.